5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.97▼ | 2.97▼ | 2.97▼ | 2.95▼ | 3.27▼ |
MA10 | 2.96▼ | 2.96▼ | 2.96▼ | 3.18▼ | 2.95▼ |
MA20 | 3.00▼ | 3.10▼ | 3.20▼ | 3.32▼ | 3.50▼ |
MA50 | 3.29▼ | 3.35▼ | 3.28▼ | 2.90▼ | 4.42▼ |
MA100 | 3.29▼ | 2.91▼ | 2.81▲ | 3.53▼ | 7.76▼ |
MA200 | 3.03▼ | 3.48▼ | 3.65▼ | 4.16▼ | 34.32▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.008▲ | -0.011▼ | -0.036▼ | -0.093▼ | 0.082▲ |
RSI | 42.218▼ | 38.252▼ | 39.451▼ | 40.095▼ | 40.661▼ |
STOCH | 44.792 | 23.528 | 17.721▼ | 11.104▼ | 67.627 |
WILL %R | -92.393▼ | -96.825▼ | -97.322▼ | -90.123▼ | -52.842 |
CCI | -83.948 | -90.419 | -86.841 | -99.436 | -2.998 |
Saturday, June 14, 2025 06:51 AM
Evoke Pharma, Inc. ( NASDAQ:EVOK ) is possibly approaching a major achievement in its business, so we would like ...
|
Tuesday, May 13, 2025 01:15 PM
May 13, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis on GIMOTI , today ...
|
Monday, April 28, 2025 05:43 AM
April 28, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis on GIMOTI ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.93 | 2.9658 | 2.78 | 2.8926 | 17,835 |
12/06/25 | 2.8536 | 3.0836 | 2.83 | 2.95 | 10,635 |
11/06/25 | 2.885 | 3.09 | 2.83 | 3.00 | 37,581 |
10/06/25 | 2.87 | 2.93 | 2.87 | 2.87 | 58,320 |
09/06/25 | 3.055 | 3.12 | 2.8501 | 3.0153 | 8,187 |
06/06/25 | 3.46 | 3.6292 | 2.9201 | 2.95 | 54,639 |
05/06/25 | 3.49 | 3.6548 | 3.23 | 3.4641 | 13,735 |
04/06/25 | 3.516 | 3.635 | 3.38 | 3.495 | 18,308 |
03/06/25 | 3.5999 | 3.5999 | 3.5999 | 3.5999 | 4,058 |
02/06/25 | 3.51 | 3.70 | 3.3559 | 3.5647 | 11,647 |
|
|
||||
|
|
||||
|
|